Modulation of neuroimmune responses on glia in the central nervous system: Implication in therapeutic intervention against neuroinflammation

Cellular and Molecular Immunology

Volumn 6, Issue 5, 2009, Pages 317-326

  Chang, Raymond Chuen Chung ^a,b   Chiu, Kin ^a   Ho, Yuen Shan ^a   So, Kwok Fai ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Microglia; Neural cell adhesion molecule; Neuroinflammation; Neurotrophins; Potassium ions

Indexed keywords

ANIMAL; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; GLIA; HUMAN; IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; ARTICLE; BRAIN PROTECTION; CELL ACTIVATION; CELL INTERACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENCEPHALITIS; EXTRACELLULAR MATRIX; GLAUCOMA; GLIA CELL; HORMONE ACTION; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MICROENVIRONMENT; NERVE CELL LESION; NERVE REGENERATION; NEUROLOGIC DISEASE; NONHUMAN; POTASSIUM CELL LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RETINA MACULA DEGENERATION; ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYCIUM; NEUROPROTECTION; PROTEIN EXPRESSION;

ANIMALS; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNE SYSTEM PROCESSES; IMMUNOTHERAPY; INFLAMMATION; NEUROGLIA; NEUROIMMUNOMODULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALPHA INTERMEDIN; AUTACOID; CELL ADHESION MOLECULE; ESTRADIOL; GLATIRAMER; GLUTAMIC ACID; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR; NEUROHORMONE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; NORADRENALIN; POTASSIUM ION; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASOACTIVE INTESTINAL POLYPEPTIDE; CD200 RECEPTOR; CYTOKINE; POLYSACCHARIDE;

EID: 70350761691     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.42     Document Type: Article

References (104)

1. Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans. 2007;35: 1122-1126.
2. Schwartz M, Kipnis J. Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci. 2005;233:163-166.
3. Crutcher KA, Gendelman HE, Kipnis J, et al. Debate: –is increasing neuroinflammation beneficial for neural repair?—. J Neuroimmune Pharmacol. 2006;1:195-211.
4. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(Suppl l):S232-240.
5. Schwartz M, London A. Immune maintenance in glaucoma: boosting the body's own neuroprotective potential. J Ocul Biol Dis Infor. 2009;2:73-77.
6. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol. 1977;25:1-54.
7. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res. 1991;28:254-260.
8. Neumann H, Misgeld T, Matsumuro K, Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U SA. 1998;95:5779-5784.
9. Bauer J, Wekerle H, Lassmann H. Apoptosis in brain-specific autoimmune disease. Curr Opin Immunol. 1995;7:839-843.
10. Perry VH, Andersson PB, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 1993;16:268-273.
11. Bianchi M, Sacerdote P, Panerai AE. Cytokines and cognitive function in mice. Biol Signals Recept. 1998;7:45-54.
12. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50:2041-2056.
13. Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001; 933;211-221.
14. Chang RCC, Stadlin A, Tsang D. Effects of tumor necrosis factor alpha on taurine uptake in cultured rat astrocytes. Neurochem Int. 200 lb;38:249-254.
15. Hirschberg DL, Schwartz M. Macrophage recruitment to acutely injured central nervous system is inhibited by a resident factor: a basis for an immune-brain barrier. J Neuroimmunol. 1995;61:89-96.
16. Zeev-Brann AB, Lazarov-Spiegler O, Brenner T, Schwartz M. Differential effects of central and peripheral nerves on macrophages and microglia. Glia. 1998;23:181-190.
17. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci. 1994;6:712-724.
18. Frohman EM, Vayuvegula B, Gupta S, van den Noort S. Norepinephrine inhibits y-interferon-induced major histocompatibility class II (la) antigen expression on cultured astrocytes via P-2-adrenergic signal transduction mechanisms. Proc Natl Acad Sci USA. 1988b;85:1292-1296.
19. Dello Russo C, Boulleme AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1P production. J Neuroinflamm. 2004;1:9.
20. Frohman EM, Frohman TC, Vayuvegula B, Gupta S, van den Noort S. Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytes. J Neurol Sci. 1988a;88:339-346.
21. Kim WK, Kan Y, Ganea D, Hart RP, Gozes I, Jonakait GM. Vasoactive intestinal peptide and pituitary adenylyl cyclaseactivating polypeptide inhibit tumor necrosis factor-a production in injured spinal cord and in activated microglia via a cAMP-dependent pathway. J Neurosci. 2000;20:3622-3630.
22. Si Q, Nakamura Y, Ogata T, Kataoka K, Schubert P. Differential regulation of microglial activation by propentofylline via cAMP signaling. Brain Res. 1998;812:97-104.
23. Lee SC, Collins M, Vanguri P, Shin ML. Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol. 1992;148:3391-3397.
24. Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther. 1997;280:61-66.
25. Kong LY, Jeohn G, Hudson PM, Du L, Liu B, Hong JS. Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins. J Biomed Sci. 2000;7:241-247.
26. Liu B, Qm L, Yang SN, Wilson BC, Liu Y, Hong JS. Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Ther. 2001;298:1133-1141.
27. Chang RCC, Rota C, Glover RE, Mason RP, Hong JS. A novel effect of an opioid receptor antagonist, naloxone, on the production of reactive oxygen species by microglia: a study by electron paramagnetic resonance spectroscopy. Brain Res. 2000;854:224-229.
28. Galimberti D, Baron P, Meda L, et al. a-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-a by microglial cells activated with β-amyloid and interferon y. Biochem Biophys Res Commun. 1999;263:251-256.
29. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF. Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology. 1999;141:3646-3656.
30. Vegeto E, Bonincontro C, Pollio G, et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. JNeurosci. 2001;21:1809-1818.
31. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol. 1997;143:313-318.
32. Vollmar P, Haghikia A, Dermietzel R, Faustmann PM. Venlafaxine exhibits an anti-inflammatory effect in an inflammatory co-culture model. Int J Neuropsychopharmacol. 2008;11:111-117.
33. Neumann H., Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science. 1995;269:549-552.
34. Neumann H, Boucraut J, Hahnel C, Misgeld T, Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci. 1996;8:2582-2590.
35. Wei R, Jonakait GM. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta 1 (TGF-J31) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. JNeuroimmunol. 1999;95:8-18.
36. Flugel A, Matsumuro K, Neumann H, et al. Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur J Immunol. 2001;31:11-22.
37. Nakajima K, Kikuchi Y, Ikoma E. et al. Neurotrophins regulate the function of cultured microglia. Glia. 1998;24:272-289.
38. Bodmer S, Strommer K, Frei K, et al. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol. 1989;143:3222-3229.
39. Kuppner MC, Hamou MF, Sawamura Y, Bodmer S, de Tribolet N. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2. J Neurosurg. 1989;71:211-217.
40. Fontana A, Bodmer S, Frei K, Malipiero U, Siepl C. Expression of TGF-β2 in human glioblastoma: a role in resistance to immune rejection? Ciba Found Symp. 1991;157:232-238.
41. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol. 1992;117:395-400.
42. Jones LL, Kreutzberg GW, Raivich G. Transforming growth factor beta's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer. Brain Res. 1998;795:301-306.
43. Qian L, Wei SJ, Zhang D, et al. Potent anti-inflammatory and neuroprotective effects of TGF-β1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol. 2008;181:660-668.
44. Xiao BG, Bai XF, Zhang GX, Link H. Transforming growth factor-beta 1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression. Neurosci Lett. 1997;226:71-74.
45. Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E. Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol. 2000; 156:139-150.
46. Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature. 1997;388:878-881.
47. Laskowitz DT, Goel S, Bennett ER, Matthew WD. Apolipoprotein E suppresses glial cell secretion of TNF alpha. J Neuroimmunol. 1997;76:70-74.
48. Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol. 2001;114:107-113.
49. Laskowitz DT, Thekdi AD, Thekdi SD, et al. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp Neurol. 2001;167:74-85.
50. Lyons A, Lynch AM, Downer EJ, et al. Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem. 2009;110:1547-1556.
51. Harrison JK, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci USA. 1998;95:10896-10901.
52. Nishiyori A, Minami M, Ohtani Y, et al. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett. 1998;429:167-172.
53. Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol. 1999;163:1628-1635.
54. Tong N, Perry SW, Zhang Q, et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol. 2000;164:1333-1339.
55. Gosselin RD, Dansereau MA, Pohl M, et al. Chemokine network in the nervous system: a new target for pain relief. Curr Med Chem. 2008;15:2866-2875.
56. McMillian MK, Thai L, Hong JS, O'Callaghan JP, Pennypacker KR. Brain injury in a dish: a model for reactive gliosis. Trends Neurosci. 1994;17:138-142.
57. McMillian MK, Pennypacker KR, Thai L, et al. Dexamethasone and forskolin synergistically increase [Met5] enkephalin accumulation in mixed brain cell cultures. Brain Res. 1996; 730:67-74.
58. Chang RCC, Hudson P, Wilson B, Haddon L, Hong JS. Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-alpha by cultured glia. Brain Res. 2000a;853:236-244.
59. Chang RCC, Chen W, Hudson P, Wilson B, Han DS, Hong JS. Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J Neurochem. 2001a;76:1042-1049.
60. Edelman GM. Cell adhesion molecule expression and the regulation of morphogenesis. Cold Spring Harb Symp Quant Biol. 1985;50:877-889.
61. Sporns O, Edelman GM, Crossin KL. The neural cell adhesion molecule (N-CAM) inhibits proliferation in primary cultures of rat astrocytes. Proc Natl Acad Sci USA. 1995;92:542-546.
62. Krushel LA, Sporns O, Cunningham BA, Crossin KL, Edelman GM. Neural cell adhesion molecule (N-CAM) inhibits astrocyte proliferation after injury to different regions of the adult rat brain. Proc Natl Acad Sci USA. 1995;92:4323-4327.
63. Chang RCC, Hudson P, Wilson B, et al. Immune modulatory effects of neural cell adhesion molecules on lipopolysaccharide-induced nitric oxide production by cultured glia. Brain Res Mol Brain Res. 2000b;81:197-201.
64. Krushel LA, Tai MH, Cunningham BA, Edelman GM, Crossin KL. Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci USA. 1998;95: 2592-2596.
65. Crossin KL, Tai MH, Krushel LA, Mauro VP, Edelman GM. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation. Proc Natl Acad Sci USA. 1997;94: 2687-2692.
66. Ackley RL, Madison RD, Archibald SJ, Hemperly JJ. Monoclonal antibody interaction with the third immunoglobulin-like domain of N-CAM Is sufficient to cause cell migration. Mol Cell Neurosci. 1997;10:117-129.
67. Downer EJ, Cowley TR, Lyons A, et al. A novel antiinflammatory role of NCAM-derived mimetic peptide, LGL. Neurobiol Aging. 2008; in press.
68. Downer EJ, Cowley TR, Cox L, et al. A synthetic NCAM-derived mimetic peptide, LGL, exerts anti-inflammatory properties via IGL-1 and interferon-gamma modulation. J Neurochem. 2009;109:1516-1525.
69. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000;290:1768-1771.
70. Dick AD, Broderick C, Lorrester JV, Wright GJ. Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci. 2001;42:170-176.
71. Chitnis T, Imitola J, Wang Y, et al. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am J Pathol. 2007;170:1695-1712.
72. Koning N, Swaab DL, Hoek RM, Huitinga I. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions. J Neuropathol Exp Neurol. 2009;68:159-67.
73. Lyons A, McQuillan K, Deighan BE, et al. Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide. Brain Behav Immun. 2009; in press.
74. Tan, L, Young PR, Barone EC, Eeuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res. 1996;36:287-291.
75. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-y. J Neurosci. 1997;17:3664-3674.
76. Koistinaho J, Pasonen S, Yrjanheikki J, Chan PH. Spreading depression-induced gene expression is regulated by plasma glucose. Stroke. 1999;30:114-119.
77. Hossmann KA. Periinfarct depolarizations. Cerebrovasc. Brain Metab Rev. 1996;8:195-208.
78. Eder C. Ion channels in microglia (brain macrophages). Am J Physiol. 1998;275:C327-C342.
79. Norenberg W, Gebicke-Haerter PJ, Illes P. Inflammatory stimuli induce a new K+ outward current in cultured rat microglia. Neurosci Lett. 1992;147:171-174.
80. Illes P, Norenberg W, Gebicke-Haerter PJ. Molecular mechanisms of microglial activation. B. Voltage-and purinoceptor-operated channels in microglia. Neurochem Int. 1996;29:13-24.
81. Gehrmann J, Mies G, Bonnekoh P, et al. Microglial reaction in the rat cerebral cortex induced by cortical spreading depression. Brain Pathol. 1993;3:11-17.
82. Chang RCC, Hudson PM, Wilson BC, Liu B, Abel H, Hong JS. High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures. Neuroscience. 2000c;97:757-764.
83. Kraig RP, Dong LM, Thisted R, Jaeger CB. Spreading depression increases immunohistochemical staining of glial fibrillary acidic protein. J Neurosci. 1991;11:2187-2198.
84. Kreutzberg GW. Microglia, the first line of defense in brain pathologies. Arzneimittelforschung 1995;45:357-360.
85. Langosch JM, Gebicke-Haerter PJ, Norenberg W, Illes P. Characterization and transduction mechanisms of purinoceptors in activated rat microglia. Br J Pharmacol. 1994; 113:29-34.
86. Wang X, Franciosi S, Bae JH, Kim SU, McLamon JG. Expression of P2y and P2x receptors in cultured human microglia. Proc West Pharmacol Soc. 1999;42:79-81.
87. McLarnon JG, Zhang L, Goghari V, et al. Effects of ATP and elevated K+ on K+ currents and intracellular Ca2+ in human microglia. Neuroscience. 1999;91:343-352.
88. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med. 1997;185:579-582.
89. Hide I, Tanaka M, Inoue A, et al. Extracellular ATP triggers tumor necrosis factor-a release from rat microglia. J Neurochem. 2000;75:965-972.
90. Naumov AP, Kuryshev YA, Kaznacheyeva EV, Mozhayeva GN. ATP-activated Ca2+-permeable channels in rat peritoneal macrophages. FEBS Lett. 1992;313:285-287.
91. Ferrari D, Stroh C, Schulze-Osthoff K. P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem. 1999;274:13205-13210.
92. Orr AG, Orr AL, Li XJ, Gross RE, Traynelis SF. Adenosine A2A receptor mediates microglial process retraction. Nature Neurosci. 2009;12:872-878.
93. Wollmer MA, Lucius R, Wilms H, Held-Feindt J, Sievers J, Mentlein R. ATP and adenosine induce ramification of microglia in vitro. J Neuroimmunol. 2001;115:19-27.
94. Schwartz M, Kipnis J. A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. Trends Pharmacol Sci. 2004;25:407-412.
95. Shaked I, Porat Z, Gersner R, Kipnis J, Schwartz M. Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol. 2004;146:84-93.
96. Kipnis J, Mizrahi T, Hauben E, Shaked I, Shevach E, Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+ CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci USA. 2002; 99:15620-15625.
97. Kipnis J, Avidan H, Caspi RR, Schwartz M. Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia. Proc Natl Acad Sci USA. 2004;101(Suppl 2): 14663-14669.
98. Nguyen VT, Benveniste EN. IL-4-activated STAT-6 inhibits IFN-y-induced CD40 gene expression in macrophages/microglia. J Immunol. 2000;165:6235-6243.
99. Sholl-Franco A, Figueiredo KG A, de Arauji EG. Interleukin-2 and interleukin-4 increase the survival of retinal ganglion cells in culture. Neuroreport. 2001;12:109-112.
100. Schwartz M. Modulating the immune system: a vaccine for glaucoma? Can J Ophthalmol. 2007;42:439-441.
101. Butovsky O, Koronyo-Hamaoui M, Kunis G, et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA. 2006; 103:11784-11789.
102. Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res. 2008;33:1011-1013.
103. Chiu K, Chan HC, Yeung SC, et al. Modulation of microglia by Wolfberry on the survival of retinal ganglion cells in a rat ocular hypertension model. J Ocular Biol Dis Informatics. 2009;2:47-56.
104. Herx LM, Rivest S, Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-lp is required for the production of ciliary neurotrophic factor. J Immunol. 2000;165:2232-2239.